2025-03-06 |
2025-03-04 |
PS
Planned sale
|
Metzger Michael A
Chief Executive Officer
Executive Director
|
7,814
-2.5%
15.05
USD 117,564
|
7,814
-2.5%
|
15.05
|
USD 117,564
|
|
2025-02-12 |
2025-02-10 |
S
Sale
|
Gallagher Neil
President, Head of R&D
Officer
|
4,618
-5.1%
15.50
USD 71,597
|
4,618
-5.1%
|
15.50
|
USD 71,597
|
|
2025-02-12 |
2025-02-10 |
S
Sale
|
Metzger Michael A
Chief Executive Officer
Executive Director
|
13,288
-4.2%
15.50
USD 206,017
|
13,288
-4.2%
|
15.50
|
USD 206,017
|
|
2025-02-12 |
2025-02-10 |
S
Sale
|
Goldan Keith A.
Chief Financial Officer
Officer
|
3,777
-4.0%
15.50
USD 58,559
|
3,777
-4.0%
|
15.50
|
USD 58,559
|
|
2024-06-17 |
2024-06-14 |
B
Purchase
|
Goldan Keith A.
Chief Financial Officer
Officer
|
1,250
+2.4%
20.03
USD 25,037
|
1,250
+2.4%
|
20.03
|
USD 25,037
|
|
2023-08-10 |
2023-08-09 |
S
Sale
|
Morrison Briggs
Non-Executive Director
|
52,855
-74.8%
18.27
USD 965,402
|
52,855
-74.8%
|
18.27
|
USD 965,402
|
|
2023-08-03 |
2023-08-02 |
S
Sale
|
Meury William
Non-Executive Director
|
24,000
-33.3%
20.45
USD 490,913
|
24,000
-33.3%
|
20.45
|
USD 490,913
|
|
2023-08-03 |
2023-08-02 |
S
Sale
|
Meury William
Non-Executive Director
|
24,000
-33.3%
20.46
USD 490,951
|
24,000
-33.3%
|
20.46
|
USD 490,951
|
|
2023-08-03 |
2023-08-02 |
S
Sale
|
Meury William
Non-Executive Director
|
35,000
-42.2%
20.46
USD 715,946
|
35,000
-42.2%
|
20.46
|
USD 715,946
|
|
2023-07-11 |
2023-07-10 |
S
Sale
|
Morrison Briggs
Non-Executive Director
|
52,855
-74.8%
20.40
USD 1,078,068
|
52,855
-74.8%
|
20.40
|
USD 1,078,068
|
|
2023-06-14 |
2023-06-13 |
S
Sale
|
Goldan Keith A.
Chief Financial Officer
Officer
|
577
-18.0%
22.31
USD 12,873
|
577
-18.0%
|
22.31
|
USD 12,873
|
|
2023-06-09 |
2023-06-09 |
S
Sale
|
Morrison Briggs
Non-Executive Director
|
28,273
-61.3%
21.18
USD 598,797
|
28,273
-61.3%
|
21.18
|
USD 598,797
|
|
2023-06-09 |
2023-06-09 |
S
Sale
|
Morrison Briggs
Non-Executive Director
|
24,582
-34.8%
21.18
USD 520,625
|
24,582
-34.8%
|
21.18
|
USD 520,625
|
|
2023-05-10 |
2023-05-09 |
S
Sale
|
Morrison Briggs
Non-Executive Director
|
52,855
-74.8%
21.41
USD 1,131,478
|
52,855
-74.8%
|
21.41
|
USD 1,131,478
|
|
2023-04-12 |
2023-04-10 |
S
Sale
|
Morrison Briggs
Non-Executive Director
|
52,855
-74.8%
19.53
USD 1,032,237
|
52,855
-74.8%
|
19.53
|
USD 1,032,237
|
|
2023-03-14 |
2023-03-13 |
PS
Planned sale
|
Morrison Briggs
President, Head of R&D
Executive Director
|
52,854
-74.8%
22.53
USD 1,190,674
|
52,854
-74.8%
|
22.53
|
USD 1,190,674
|
|
2023-02-17 |
2023-02-15 |
PS
Planned sale
|
Ordentlich Peter
Chief Scientific Officer
Officer
|
17,428
-100.0%
25.84
USD 450,404
|
17,428
-100.0%
|
25.84
|
USD 450,404
|
|
2023-02-17 |
2023-02-15 |
PS
Planned sale
|
Ordentlich Peter
Chief Scientific Officer
Officer
|
7,572
-100.0%
25.84
USD 195,688
|
7,572
-100.0%
|
25.84
|
USD 195,688
|
|
2023-02-08 |
2023-02-06 |
PS
Planned sale
|
Morrison Briggs
President, Head of R&D
Executive Director
|
52,854
-74.8%
26.83
USD 1,417,909
|
52,854
-74.8%
|
26.83
|
USD 1,417,909
|
|
2023-02-08 |
2023-02-06 |
PS
Planned sale
|
Metzger Michael A
Chief Executive Officer
Executive Director
|
5,959
-25.2%
27.64
USD 164,697
|
5,959
-25.2%
|
27.64
|
USD 164,697
|
|
2023-02-03 |
2023-02-01 |
S
Sale
|
Ordentlich Peter
Chief Scientific Officer
Officer
|
69
-100.0%
28.43
USD 1,962
|
69
-100.0%
|
28.43
|
USD 1,962
|
|
2023-01-13 |
2023-01-13 |
PS
Planned sale
|
Legault Pierre
Non-Executive Director
|
5,000
-13.5%
27.00
USD 135,000
|
5,000
-13.5%
|
27.00
|
USD 135,000
|
|
2023-01-13 |
2023-01-13 |
PS
Planned sale
|
Legault Pierre
Non-Executive Director
|
10,000
-23.8%
27.00
USD 270,000
|
10,000
-23.8%
|
27.00
|
USD 270,000
|
|
2023-01-13 |
2023-01-12 |
PS
Planned sale
|
Legault Pierre
Non-Executive Director
|
24,000
-42.9%
26.74
USD 641,782
|
24,000
-42.9%
|
26.74
|
USD 641,782
|
|
2022-12-02 |
2022-12-02 |
PS
Planned sale
|
Ordentlich Peter
Chief Scientific Officer
Officer
|
17,200
-98.5%
25.05
USD 430,936
|
17,200
-98.5%
|
25.05
|
USD 430,936
|
|
2022-12-02 |
2022-12-01 |
PS
Planned sale
|
Ordentlich Peter
Chief Scientific Officer
Officer
|
4,028
-93.8%
25.01
USD 100,746
|
4,028
-93.8%
|
25.01
|
USD 100,746
|
|
2022-12-02 |
2022-12-01 |
PS
Planned sale
|
Ordentlich Peter
Chief Scientific Officer
Officer
|
3,772
-93.4%
25.01
USD 94,343
|
3,772
-93.4%
|
25.01
|
USD 94,343
|
|
2022-10-07 |
2022-10-06 |
PS
Planned sale
|
Katkin Keith
Non-Executive Director
|
9,117
-22.2%
25.90
USD 236,139
|
9,117
-22.2%
|
25.90
|
USD 236,139
|
|
2022-10-07 |
2022-10-06 |
PS
Planned sale
|
Katkin Keith
Non-Executive Director
|
20,782
-39.4%
25.90
USD 538,273
|
20,782
-39.4%
|
25.90
|
USD 538,273
|
|
2022-10-07 |
2022-10-06 |
PS
Planned sale
|
Metzger Michael A
Chief Executive Officer
Executive Director
|
16,231
-47.9%
25.29
USD 410,508
|
16,231
-47.9%
|
25.29
|
USD 410,508
|
|
2022-10-04 |
2022-10-04 |
PS
Planned sale
|
Metzger Michael A
Chief Executive Officer
Executive Director
|
1,280
-6.8%
25.02
USD 32,026
|
1,280
-6.8%
|
25.02
|
USD 32,026
|
|
2022-10-04 |
2022-10-04 |
PS
Planned sale
|
Katkin Keith
Non-Executive Director
|
223
-0.7%
25.00
USD 5,575
|
223
-0.7%
|
25.00
|
USD 5,575
|
|
2022-10-04 |
2022-10-04 |
PS
Planned sale
|
Katkin Keith
Non-Executive Director
|
137
-0.4%
25.00
USD 3,425
|
137
-0.4%
|
25.00
|
USD 3,425
|
|
2022-10-04 |
2022-10-03 |
PS
Planned sale
|
Metzger Michael A
Chief Executive Officer
Executive Director
|
2,883
-14.0%
25.01
USD 72,107
|
2,883
-14.0%
|
25.01
|
USD 72,107
|
|
2022-10-04 |
2022-10-03 |
PS
Planned sale
|
Katkin Keith
Non-Executive Director
|
13
-0.0%
25.00
USD 325
|
13
-0.0%
|
25.00
|
USD 325
|
|
2022-10-04 |
2022-10-03 |
PS
Planned sale
|
Katkin Keith
Non-Executive Director
|
167
-0.5%
25.00
USD 4,175
|
167
-0.5%
|
25.00
|
USD 4,175
|
|
2022-10-04 |
2022-09-30 |
PS
Planned sale
|
Metzger Michael A
Chief Executive Officer
Executive Director
|
29,606
-62.6%
25.02
USD 740,757
|
29,606
-62.6%
|
25.02
|
USD 740,757
|
|
2022-10-04 |
2022-09-30 |
PS
Planned sale
|
Katkin Keith
Non-Executive Director
|
647
-2.0%
25.07
USD 16,221
|
647
-2.0%
|
25.07
|
USD 16,221
|
|
2022-10-04 |
2022-09-30 |
PS
Planned sale
|
Katkin Keith
Non-Executive Director
|
2,914
-8.3%
25.07
USD 73,056
|
2,914
-8.3%
|
25.07
|
USD 73,056
|
|
2022-09-21 |
2022-09-20 |
PS
Planned sale
|
Morrison Briggs
President, Head of R&D
Executive Director
|
59,649
-77.0%
23.25
USD 1,387,012
|
59,649
-77.0%
|
23.25
|
USD 1,387,012
|
|
2022-09-21 |
2022-09-19 |
PS
Planned sale
|
Morrison Briggs
President, Head of R&D
Executive Director
|
114,339
-86.5%
23.03
USD 2,633,044
|
114,339
-86.5%
|
23.03
|
USD 2,633,044
|
|
2022-09-16 |
2022-09-16 |
PS
Planned sale
|
Podlesak Dennis
Non-Executive Director
|
6,556
-8.0%
23.43
USD 153,625
|
6,556
-8.0%
|
23.43
|
USD 153,625
|
|
2022-09-16 |
2022-09-16 |
PS
Planned sale
|
Podlesak Dennis
Non-Executive Director
|
5,419
-6.7%
23.43
USD 126,982
|
5,419
-6.7%
|
23.43
|
USD 126,982
|
|
2022-09-16 |
2022-09-16 |
PS
Planned sale
|
Morrison Briggs
President, Head of R&D
Executive Director
|
53,034
-74.8%
23.22
USD 1,231,423
|
53,034
-74.8%
|
23.22
|
USD 1,231,423
|
|
2022-09-16 |
2022-09-16 |
PS
Planned sale
|
Morrison Briggs
President, Head of R&D
Executive Director
|
71,966
-80.1%
23.22
USD 1,671,015
|
71,966
-80.1%
|
23.22
|
USD 1,671,015
|
|
2022-09-16 |
2022-09-15 |
PS
Planned sale
|
Podlesak Dennis
Non-Executive Director
|
66,840
-46.9%
24.20
USD 1,617,381
|
66,840
-46.9%
|
24.20
|
USD 1,617,381
|
|
2022-09-16 |
2022-09-15 |
PS
Planned sale
|
Morrison Briggs
President, Head of R&D
Executive Director
|
66,775
-78.9%
24.20
USD 1,616,035
|
66,775
-78.9%
|
24.20
|
USD 1,616,035
|
|
2022-09-16 |
2022-09-14 |
PS
Planned sale
|
Morrison Briggs
President, Head of R&D
Executive Director
|
87,645
-83.1%
23.80
USD 2,085,855
|
87,645
-83.1%
|
23.80
|
USD 2,085,855
|
|
2022-08-26 |
2022-08-24 |
PS
Planned sale
|
Ordentlich Peter
Chief Scientific Officer
Officer
|
2,154
-89.0%
25.04
USD 53,927
|
2,154
-89.0%
|
25.04
|
USD 53,927
|
|
2022-08-26 |
2022-08-24 |
PS
Planned sale
|
Ordentlich Peter
Chief Scientific Officer
Officer
|
22,846
-98.9%
25.04
USD 571,966
|
22,846
-98.9%
|
25.04
|
USD 571,966
|
|
2022-08-09 |
2022-08-05 |
PS
Planned sale
|
Legault Pierre
Non-Executive Director
|
14,000
-30.4%
23.02
USD 322,223
|
14,000
-30.4%
|
23.02
|
USD 322,223
|
|
2022-08-09 |
2022-08-05 |
PS
Planned sale
|
Legault Pierre
Non-Executive Director
|
10,000
-23.8%
23.02
USD 230,159
|
10,000
-23.8%
|
23.02
|
USD 230,159
|
|
2022-07-27 |
2022-07-25 |
PS
Planned sale
|
Metzger Michael A
Chief Executive Officer
Executive Director
|
11,838
-40.1%
21.06
USD 249,254
|
11,838
-40.1%
|
21.06
|
USD 249,254
|
|
2022-07-27 |
2022-07-25 |
PS
Planned sale
|
Metzger Michael A
Chief Executive Officer
Executive Director
|
19,764
-52.8%
21.06
USD 416,139
|
19,764
-52.8%
|
21.06
|
USD 416,139
|
|
2022-07-08 |
2022-07-07 |
PS
Planned sale
|
Metzger Michael A
Chief Executive Officer
Executive Director
|
100
-0.6%
21.00
USD 2,100
|
100
-0.6%
|
21.00
|
USD 2,100
|
|
2022-07-08 |
2022-07-06 |
PS
Planned sale
|
Metzger Michael A
Chief Executive Officer
Executive Director
|
15,009
-45.9%
21.07
USD 316,307
|
15,009
-45.9%
|
21.07
|
USD 316,307
|
|
2022-07-05 |
2022-07-01 |
PS
Planned sale
|
Morrison Briggs
President, Head of R&D
Executive Director
|
62,292
-77.7%
19.00
USD 1,183,430
|
62,292
-77.7%
|
19.00
|
USD 1,183,430
|
|
2022-04-05 |
2022-04-04 |
PS
Planned sale
|
Morrison Briggs
President, Head of R&D
Executive Director
|
3,128
-14.9%
18.29
USD 57,220
|
3,128
-14.9%
|
18.29
|
USD 57,220
|
|
2022-04-05 |
2022-04-01 |
PS
Planned sale
|
Morrison Briggs
President, Head of R&D
Executive Director
|
70,545
-79.8%
17.46
USD 1,231,568
|
70,545
-79.8%
|
17.46
|
USD 1,231,568
|
|
2022-04-05 |
2022-04-01 |
PS
Planned sale
|
Morrison Briggs
President, Head of R&D
Executive Director
|
24,500
-57.9%
17.44
USD 427,314
|
24,500
-57.9%
|
17.44
|
USD 427,314
|
|
2022-04-05 |
2022-04-01 |
PS
Planned sale
|
Morrison Briggs
President, Head of R&D
Executive Director
|
6,000
-12.4%
17.44
USD 104,633
|
6,000
-12.4%
|
17.44
|
USD 104,633
|
|
2022-02-03 |
2022-02-01 |
S
Sale
|
Nolte Alexander
Chief Accounting Officer
Officer
|
968
-100.0%
16.65
USD 16,117
|
968
-100.0%
|
16.65
|
USD 16,117
|
|
2022-02-03 |
2022-02-01 |
S
Sale
|
Ordentlich Peter
Chief Scientific Officer
Officer
|
1,412
-100.0%
16.65
USD 23,510
|
1,412
-100.0%
|
16.65
|
USD 23,510
|
|
2021-12-22 |
2021-12-22 |
PS
Planned sale
|
Legault Pierre
Non-Executive Director
|
24,000
-60.0%
22.01
USD 528,206
|
24,000
-60.0%
|
22.01
|
USD 528,206
|
|
2021-12-22 |
2021-12-20 |
PS
Planned sale
|
Legault Pierre
Non-Executive Director
|
20,000
-55.6%
21.01
USD 420,250
|
20,000
-55.6%
|
21.01
|
USD 420,250
|
|
2021-12-20 |
2021-12-20 |
PS
Planned sale
|
Metzger Michael A
President and COO
Executive Director
|
45,000
-71.8%
20.29
USD 912,960
|
45,000
-71.8%
|
20.29
|
USD 912,960
|
|
2021-12-20 |
2021-12-20 |
PS
Planned sale
|
Metzger Michael A
President and COO
Executive Director
|
16,000
-47.5%
20.29
USD 324,608
|
16,000
-47.5%
|
20.29
|
USD 324,608
|
|
2021-12-20 |
2021-12-17 |
PS
Planned sale
|
Metzger Michael A
President and COO
Executive Director
|
1,676
-8.7%
19.02
USD 31,877
|
1,676
-8.7%
|
19.02
|
USD 31,877
|
|
2021-12-20 |
2021-12-17 |
PS
Planned sale
|
Morrison Briggs
Chief Executive Officer
Executive Director
|
35,156
-42.1%
20.00
USD 703,120
|
35,156
-42.1%
|
20.00
|
USD 703,120
|
|
2021-12-20 |
2021-12-16 |
PS
Planned sale
|
Metzger Michael A
President and COO
Executive Director
|
22,715
-56.3%
19.08
USD 433,400
|
22,715
-56.3%
|
19.08
|
USD 433,400
|
|
2021-12-15 |
2021-12-13 |
PS
Planned sale
|
Metzger Michael A
President and COO
Executive Director
|
34,564
-66.2%
19.05
USD 658,555
|
34,564
-66.2%
|
19.05
|
USD 658,555
|
|
2021-12-15 |
2021-12-13 |
PS
Planned sale
|
Metzger Michael A
President and COO
Executive Director
|
2,045
-10.4%
19.05
USD 38,964
|
2,045
-10.4%
|
19.05
|
USD 38,964
|
|
2021-11-19 |
2021-11-18 |
PS
Planned sale
|
Egros Fabrice
Non-Executive Director
|
30
-0.2%
18.03
USD 541
|
30
-0.2%
|
18.03
|
USD 541
|
|
2021-11-19 |
2021-11-18 |
PS
Planned sale
|
Egros Fabrice
Non-Executive Director
|
14,000
-46.7%
18.03
USD 252,452
|
14,000
-46.7%
|
18.03
|
USD 252,452
|
|
2021-10-27 |
2021-10-26 |
PS
Planned sale
|
Metzger Michael A
President and COO
Executive Director
|
16,296
-48.0%
19.20
USD 312,825
|
16,296
-48.0%
|
19.20
|
USD 312,825
|
|